The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Dienogest Stragen 2 mg film-coated tablets

G&G Pharmaceutical (Netherlands) B.V.PA23029/001/001

Main Information

Trade NameDienogest Stragen 2 mg film-coated tablets
Active SubstancesDienogest
Dosage FormFilm-coated tablet
Licence HolderG&G Pharmaceutical (Netherlands) B.V.
Licence NumberPA23029/001/001

Group Information

ATC CodeG03DB Pregnadien derivatives
G03DB08 dienogest


License statusAuthorised
Licence Issued28/06/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back